AAL
48
-2
DOV
71
10
AXP
71
-2
AFL
45
-3
AIZ
76
-2
CMA
67
2
DRI
58
-5
CHRW
76
-3
ADI
73
-3
APD
52
2
BDX
61
2
C
81
-4
CCL
82
-4
DG
72
4
DUK
55
-2
CAG
36
2
CL
62
-2
DIS
70
-2
BF.B
33
-2
AVY
50
3
AAL
48
-2
DOV
71
10
AXP
71
-2
AFL
45
-3
AIZ
76
-2
CMA
67
2
DRI
58
-5
CHRW
76
-3
ADI
73
-3
APD
52
2
BDX
61
2
C
81
-4
CCL
82
-4
DG
72
4
DUK
55
-2
CAG
36
2
CL
62
-2
DIS
70
-2
BF.B
33
-2
AVY
50
3
Financhill
Back

UBS ETRACS Crude Oil Shs Covrd Call ETN Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
31

USOI
UBS ETRACS Crude Oil Shs Covrd Call ETN

Last Price:
$46.84
Seasonality Move:
-1.54%
Buy
78

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Sell
31
UBS ETRACS Crude Oil Shs Covrd Call ETN (USOI) is a Sell

Is UBS ETRACS Crude Oil Shs Covrd Call ETN a Buy, Sell or Hold?

  • The current UBS ETRACS Crude Oil Shs Covrd Call ETN [USOI] share price is $46.90. The Score for USOI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • USOI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

USOI Stock Price Chart

What is UBS ETRACS Crude Oil Shs Covrd Call ETN's stock price today?

  • The UBS ETRACS Crude Oil Shs Covrd Call ETN share price today is $46.90
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USOI is experiencing selling pressure, which indicates risk of future bearish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

USOI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 12.43 Buy
Relative Strength Index (14 RSI): 42.33 Sell
Chaikin Money Flow: -168352 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.13 - 48.79) Sell
Bollinger Bands (100): (48.23 - 51.55) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

USOI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.03 Sell
20-day SMA: 47.92 Sell
50-day SMA: 48.52 Sell
200-day SMA: 52.73 Sell
8-day EMA: 36.77 Buy
20-day EMA: 21.31 Buy
50-day EMA: 10.07 Buy
200-day EMA: 2.75 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

UBS ETRACS Crude Oil Shs Covrd Call ETN Earnings Growth & USOI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

UBS ETRACS Crude Oil Shs Covrd Call ETN Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):